文献速递肺栓塞与肺血管病

加强标准化体系建设,提升中国肺动脉高压规范诊疗与综合管理水平

[Strengthening the construction of standardized system to enhance the standard diagnosis, treatment and comprehensive management of pulmonary hypertension in China].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2023-01-01

本文结合新版指南及最新进展,探讨中国肺动脉高压领域诊疗现状与标准化体系建设。PH发病机制、诊断界值、分类及综合治疗快速进展促使指南更新,但国内仍存在早期识别诊断困难、个体化精准治疗待优化、规范化策略待普及等问题。

要点

  • PH临床分类、血流动力学诊断界值和靶向药物不断更新,指南持续修订。
  • PH异质性导致疾病复杂和临床处理困难,早期识别与诊断面临巨大挑战。
  • 国内需推广规范化诊治策略,优化个体化精准治疗和综合管理。

核心结论

  • PH领域快速进展促使指南更新,为国内规范诊疗和综合管理带来新挑战。
  • 国内PH早期识别诊断困难,个体化精准治疗需优化,规范化策略待普及推广。

研究设计与样本

  • 本文为结合新版指南及最新进展的述评,探讨国内PH诊疗现状与标准化体系建设。

主要发现

  • PH发病机制认识加深、循证证据增加、临床分类与血流动力学诊断界值更新、新靶向药物和干预手段出现。
  • PH异质性造成疾病复杂性和临床处理困难,早期识别与诊断面临巨大挑战。

临床怎么用

  • 临床应关注PH指南更新,推动规范化诊治策略普及与推广。
  • 对PH患者需重视早期识别与诊断,并优化个体化精准治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In recent years, there has been rapid progress in the field of pulmonary hypertension (PH). With the deeper understanding of the pathogenesis of PH, the increase of evidence-based medical evidence, the continuous updating of PH clinical classification, the hemodynamic diagnostic boundaries, and the emergence of new targeted drugs and interventions, the guidelines are constantly being updated. It brings new challenges to the standard diagnosis, treatment and comprehensive management of PH in China. Compared with the world, there are still many problems in the field of PH in China. The heterogeneity of PH causes the complexity of the disease and the difficulty of clinical management, and the early identification and diagnosis of pH face great challenges. Individualized and precise treatment needs to be further optimized, and standardized diagnosis and treatment strategies need to be popularized and promoted. In recent years, rapid progress has been made in the field of PH, including its pathogenesis, diagnostic thresholds, classification and comprehensive treatment methods, prompting an update of the guidelines, which brings a new level of standardized diagnosis and comprehensive management of PH in China. This guideline brings new challenges to the standardized diagnosis and treatment and comprehensive management of PH in China. Here, we discussed in depth the current situation of diagnosis and treatment in the field of PH, as well as the development of a standardized system for PH in China. 肺动脉高压(pulmonary hypertension,PH)领域近年来取得了迅猛的进展,随着对PH发病机制认识加深,循证医学证据不断增加,PH临床分类、血流动力学诊断界值不断更新、新的靶向药物和干预手段也不断出现,促使指南不断更新,为国内PH的规范诊疗和综合管理水平带来新的挑战。基于国际视角,我国在PH领域仍存在诸多问题,PH的异质性造成了疾病的复杂性和临床处理的困难,其早期识别与诊断面临巨大挑战,个体化、精准化治疗需要进一步优化,规范化和标准化诊治策略有待普及和推广。本文结合新版指南及最新进展,就国内PH领域诊疗现状和肺动脉高压标准化体系建设进行探讨。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhai ZG, Yang YH, Wang C, et al. [Strengthening the construction of standardized system to enhance the standard diagnosis, treatment and comprehensive management of pulmonary hypertension in China]. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 37278168. doi:10.3760/cma.j.cn112147-20230418-00185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。